Home / News / India News / Article / Covaxin for Children will take some more time for final approval: Sources

Covaxin for Children will take some more time for final approval: Sources

Recently, the Subject Expert Committee (SEC) had given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's Covaxin COVID-19 vaccine for the beneficiaries aged between 2-18 years

  • WhatsAppBookmarkBookmark
Listen to this article :
Representational Image

Representational Image

The data for Bharat Biotech's Covaxin for Children, COVID-19 vaccine, is under evaluation and the process will take some more time for final approval from the Drugs Controller General of India (DCGI), sources said. "It's a sensitive matter. Data evaluation is underway. More data has been submitted," sources informed ANI.

Recently, the Subject Expert Committee (SEC) had given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's Covaxin COVID-19 vaccine for the beneficiaries aged between 2-18 years. After evaluation of the data, the final approval will be given by the Drug Controller General of India (DCGI).

Read Next Story
George Fernandes, Arun Jaitley, Sushma Swaraj posthumously conferred Padma Vibhushan›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All